🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, asserting the companies withheld safety concerns that the medication posed to pediatric brain development.

The lawsuit follows thirty days after Donald Trump publicized an unproven link between taking Tylenol - referred to as paracetamol - during pregnancy and autism spectrum disorder in children.

The attorney general is suing J&J, which previously sold the drug, the exclusive pain medication suggested for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he claimed they "deceived the public by making money from suffering and pushing pills ignoring the potential hazards."

The manufacturer asserts there is insufficient reliable data linking acetaminophen to autism.

"These manufacturers lied for decades, knowingly endangering numerous people to increase profits," the attorney general, from the Republican party, stated.

The manufacturer stated officially that it was "very worried by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the welfare of American women and children."

On its website, Kenvue also said it had "regularly reviewed the relevant science and there is lacking reliable evidence that demonstrates a proven link between consuming paracetamol and autism."

Organizations speaking for physicians and health professionals concur.

ACOG has declared acetaminophen - the main ingredient in Tylenol - is among limited choices for women during pregnancy to treat pain and elevated temperature, which can present significant medical dangers if left untreated.

"In multiple decades of investigation on the utilization of paracetamol in pregnancy, not a single reputable study has conclusively proven that the usage of paracetamol in any stage of pregnancy results in brain development issues in offspring," the association stated.

This legal action mentions latest statements from the previous government in asserting the drug is reportedly hazardous.

Recently, Trump raised alarms from medical authorities when he told expectant mothers to "resist strongly" not to consume Tylenol when unwell.

The US Food and Drug Administration then issued a notice that medical professionals should contemplate reducing the use of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had vowed in spring to conduct "extensive scientific investigation" that would establish the source of autism spectrum disorder in a matter of months.

But experts advised that finding a unique factor of autism - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would prove challenging.

Autism is a form of enduring cognitive variation and impairment that impacts how persons experience and relate to the world, and is recognized using medical professional evaluations.

In his court filing, Paxton - a Trump ally who is seeking the Senate - alleges Kenvue and J&J "willfully ignored and sought to suppress the evidence" around paracetamol and autism.

The case seeks to make the corporations "remove any promotional materials" that asserts acetaminophen is secure for pregnant women.

This legal action parallels the grievances of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in two years ago.

Judicial authorities dismissed the legal action, stating research from the family's specialists was inconclusive.